Oligospermia (Low Sperm Count) Protocol
Primary Stack
Core supplements with strongest evidenceEssential for sperm energy metabolism and motility; improves sperm concentration, motility, and morphology
Antioxidant that protects sperm from oxidative damage; improves sperm density, motility, and morphology
Supporting Stack
Additional supplements for enhanced resultsEssential for testosterone synthesis and sperm development; deficiency common in infertile men
Supporting Studies (1)
Reduces oxidative stress, improves testosterone levels, and enhances sperm quality parameters
Supporting Studies (1)
Antioxidant essential for sperm formation; component of selenoproteins needed for sperm development
Supporting Studies (1)
Essential for DNA synthesis during sperm production; deficiency associated with abnormal sperm
Traditional Ayurvedic remedy that may improve testosterone and sperm parameters
Supporting Studies (1)
May increase luteinizing hormone and testosterone; traditional use for male fertility
Supporting Studies (1)
DHA is essential for sperm membrane fluidity and function; may improve sperm morphology
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Oligospermia (low sperm count) is defined as having fewer than 15 million sperm per milliliter of semen. Along with low motility (asthenozoospermia) and abnormal morphology (teratozoospermia), it's a major cause of male factor infertility, which contributes to about 40-50% of all infertility cases. Causes include hormonal imbalances, varicocele, infections, heat exposure, oxidative stress, and nutritional deficiencies. While medical evaluation is essential to identify treatable causes, nutritional supplementation can significantly improve sperm parameters in many men.
IMPORTANT: Male infertility requires medical evaluation to identify underlying causes (varicocele, hormonal issues, infections, obstructions). This protocol supports sperm health but does not replace proper diagnosis and treatment of underlying conditions.
Expected timeline: Sperm take about 74 days to develop, so supplements need at least 3 months to show effects. Full benefits often require 3-6 months of consistent supplementation. Repeat semen analysis after 3 months of supplementation.
Clinical Perspective
Oligospermia is defined by WHO criteria as sperm concentration <15 million/mL. Often occurs with asthenozoospermia (reduced motility) and teratozoospermia (abnormal morphology) as oligoasthenoteratozoospermia (OAT). Spermatogenesis cycle is 74 days. Etiology: idiopathic (30-40%), varicocele (15-40%), hypogonadism, infections, obstruction, genetic factors (Y-chromosome microdeletions, Klinefelter), environmental exposures, medications. Oxidative stress is a common final pathway. Evaluation: semen analysis (×2), hormones (FSH, LH, testosterone, prolactin), physical exam, scrotal ultrasound, genetic testing if indicated.
CRITICAL: Evaluation required before treatment. Varicocele repair is indicated for clinical varicocele with abnormal semen. Hormonal abnormalities require endocrine evaluation. Obstruction may require surgical correction. ART (IUI, IVF, ICSI) may be needed. Supplements are adjunctive to medical management.
Biomarker targets: Semen analysis (concentration >15M/mL, progressive motility >32%, normal morphology >4%), testosterone, FSH, LH. Oxidative stress markers (MDA, 8-OHdG) if available. DNA fragmentation index if ART planned.
Protocol notes: Avoid heat exposure to testes (hot tubs, saunas, laptop on lap, tight underwear). Maintain healthy BMI—obesity impairs spermatogenesis. Avoid alcohol excess (reduces testosterone). Stop smoking (increases oxidative stress, DNA damage). Limit environmental toxins (pesticides, heavy metals, BPA). Treat varicocele if clinically significant. Manage chronic conditions (diabetes affects sperm). Review medications (some impair spermatogenesis). Intercourse timing around ovulation (every 2-3 days). Reduce stress (cortisol inhibits GnRH). Minimum 3 months supplementation before reassessment (74-day sperm cycle). Consider antioxidant combinations—oxidative stress common pathway. If severe oligospermia (<5M/mL), ART likely needed; supplements may improve sperm for ICSI.